These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 475762)

  • 21. C1 inhibitor: different mechanisms of reaction with complement component C1 and C1s.
    Hortin GL; Trimpe BL
    Immunol Invest; 1991 Feb; 20(1):75-82. PubMed ID: 2055603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosynthesis of the first component of complement by human fibroblasts.
    Reid KB; Solomon E
    Biochem J; 1977 Dec; 167(3):647-60. PubMed ID: 603627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical and functional analysis of a complete C1q deficiency in man: evidence that C1r and C1s are in the native form, and that they reassociate with purified C1q to form macromolecular C1.
    Loos M; Laurell AB; Sjöholm AG; Mårtensson U; Berkel AI
    J Immunol; 1980 Jan; 124(1):59-63. PubMed ID: 7350234
    [No Abstract]   [Full Text] [Related]  

  • 26. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
    Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
    Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
    Hidvégi T; Ermolin GA; Efremov EE; Dikov MM; Kurmanova LV; Vnashenkova GV; Merkulova MV; Kókai M; Panya A; Füst G
    Immunol Lett; 1989 Jul; 22(1):1-6. PubMed ID: 2550362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The first component of human complement (C1): activation and control.
    Ziccardi RJ
    Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
    Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
    Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assembly of subcomponents C1r and C1s of first component of complement: electron microscopic and ultracentrifugal studies.
    Tschopp J; Villiger W; Fuchs H; Kilchherr E; Engel J
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7014-8. PubMed ID: 6938949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA; Steiger G; Schapira M
    Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure and function of the first component of complement: genetic engineering approach (a review).
    Gál P; Cseh S; Schumaker VN; Závodszky P
    Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s.
    Reboul A; Arlaud GJ; Sim RB; Colomb MG
    FEBS Lett; 1977 Jul; 79(1):45-50. PubMed ID: 891934
    [No Abstract]   [Full Text] [Related]  

  • 39. The macromolecular structure of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.